Iron nanoparticle eliminates tuberculosis in mice and may pave the way for new treatments

An iron-based compound encapsulated in lipid nanoparticles completely eliminated tuberculosis in the lungs of mice after 30 days of treatment, according to a study from the Tuberculosis Research Laboratory at the Araraquara School of Pharmaceutical Sciences of the State University of São Paulo (FCFAr-UNESP) in Brazil. The study was published in the journal ACS Omega. The results suggest a possible new path toward shorter, less toxic and more effective therapies against resistant bacteria, one of the biggest challenges currently facing the fight against the disease.